ReGen Challenges FDA Report's Facts And Motivation
This article was originally published in The Gray Sheet
Executive Summary
The details of FDA's recent review of ReGen Biologics' Menaflex knee repair device clearance stunned many device industry insiders - but none so much as the company itself